Sound Pharmaceuticals IPO

soundpharmaceuticals.com

Sound Pharmaceuticals is a bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss and tinnitus. The company uses molecular biology, immunohistochemistry and electrophysiology that have lead to the development of preclinical models of hearing loss and tinnitus that are translating into successful clinical trials.

Founded2018
Total Funding to Date$25.95MM
Register for Details

For more details on financing and valuation for Sound Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Sound Pharmaceuticals Ticker Symbol

Sound Pharmaceuticals does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Sound Pharmaceuticals Stock Price

The stock price for Sound Pharmaceuticals will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Sound Pharmaceuticals

KEC Ventures
Cystic Fibrosis Foundation

Sound Pharmaceuticals Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/24/2018 Series C-2 $11.76MM raised $XXX.XX $XXX.XX
10/17/2013 Series C and C-1 $11.18MM raised $XXX.XX $XXX.XX
7/6/2006 Series B $3MM raised $XXX.XX $XXX.XX
6/30/2001 Series A $16K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Sound Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector